|
Market Closed -
Other stock markets
|
Pre-market 06:06:44 pm | |||
| 14 USD | -0.43% |
|
14.02 | +0.11% |
| 14/06 | Novavax Files Emergency Use Authorization Amendment For Updated COVID-19 Vaccine | MT |
| 14/06 | FDA asks COVID vaccine makers to target KP.2 strain with updated shots | RE |
June 7 (Reuters) - The U.S. Food and Drug Administration on Friday advised COVID-19 vaccine manufacturers that new shots for the fall 2024 campaign should target the JN.1 variant that was dominant earlier this year. (Reporting by Leroy Leo in Bengaluru; Editing by Tasim Zahid)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 133.4 USD | -0.74% | -4.73% | 51.12B | ||
| 27.74 USD | 0.00% | +0.76% | 157B | ||
| 14 USD | -0.43% | -2.78% | 1.97B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +191.67% | 1.97B | |
| +34.14% | 51.12B | |
| -6.54% | 39.4B | |
| +35.99% | 38.48B | |
| +12.62% | 26.36B | |
| -12.11% | 26.22B | |
| -13.43% | 20.96B | |
| +43.73% | 14.02B | |
| +31.81% | 12.49B | |
| -4.54% | 11.61B |
NOVAVAX, INC. 
